| 000 | 01985nam a2200469 i 4500 | ||
|---|---|---|---|
| 999 |
_c277335 _d277335 |
||
| 001 | on1062362775 | ||
| 003 | OCoLC | ||
| 005 | 20181218152349.0 | ||
| 007 | he bmb024bbca | ||
| 008 | 181109s2018 dcu bb f000 0 eng c | ||
| 040 |
_aPUCPR _beng _erda _cGPO _dMvI |
||
| 042 | _apcc | ||
| 043 | _an-us--- | ||
| 074 | _a1008-D (MF) | ||
| 086 | 0 | _aY 1.1/8:115-727 | |
| 099 | _aY 1.1/8:115-727 | ||
| 110 | 1 |
_aUnited States. _bCongress. _bHouse. _bCommittee on Energy and Commerce, |
|
| 245 | 1 | 0 |
_aMedicaid Health Home Act : _breport (to accompany H.R. 5810) (including cost estimate of the Congressional Budget Office). |
| 264 | 1 |
_a[Washington, D.C.] : _b[U.S. Government Publishing Office], _c[2018] |
|
| 300 |
_a125 pages ; _c24 cm. |
||
| 336 | _btxt | ||
| 337 |
_bh _2rdamedia |
||
| 338 |
_bhe _2rdacarrier |
||
| 490 | 1 |
_aReport / 115th Congress, 2d session, House of Representatives ; _v115-727 |
|
| 500 | _a"June 12, 2018." | ||
| 500 | _aShipping list no.: 2018-0192-M. | ||
| 500 | _aCRDP Program record. | ||
| 504 | _aIncludes bibliographical references. | ||
| 533 |
_aMicrofiche. _b[Washington, D.C.] : _cU.S. Government Printing Office, _d[2018] _e2 microfiches : negative. |
||
| 776 | 0 | 8 |
_iPrint version: _aUnited States. Congress. House. Committee on Energy and Commerce. _tMedicaid Health Home Act _w(OCoLC)1041934652 |
| 776 | 0 | 8 |
_iOnline version: _aUnited States. Congress. House. Committee on Energy and Commerce. _tMedicaid Health Home Act _w(OCoLC)1041934103 |
| 810 | 1 |
_aUnited States. _bCongress. _bHouse. _tReport ; _v115-727. |
|
| 050 | 4 |
_aKF32 _b.E55 2018t |
|
| 610 | 1 | 0 |
_aUnited States. _tSocial Security Act. |
| 650 | 0 |
_aOpioid abuse _xOverdose _zUnited States _xPrevention. |
|
| 650 | 0 |
_aChronic pain _xTreatment. |
|
| 650 | 0 |
_aMedicare fraud _xPrevention. |
|
| 650 | 0 |
_aMedicaid fraud _xPrevention. |
|
| 650 | 0 |
_aMedicare _xLaw and legislation. |
|
| 655 | 7 |
_aLegislative materials. _2lcgft |
|
| 942 |
_2sudocs _c8 |
||